iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Glenmark Pharmaceuticals Ltd Option Chain

Add as a Preferred Source on Google
1,954.2
(1.76%)
Feb 3, 2026|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Ol (lots)Call PriceStrike PricePut PriceOl (lots)
1,1250%₹331.3 0%1,640--
3750%₹344.2 0%1,680₹3.15 -34.37%18,37511.36%
3,0000%₹172 0%1,700--
--1,720₹4.4 -42.48%68,6251.10%
--1,740₹5.45 -43.52%25,875-4.16%
--1,760₹6.9 -41.02%20,62589.65%
4,50020%₹212.6 66.09%1,780₹8.65 -37.99%36,750-3.92%
9,0004.34%₹190 25.32%1,800₹10.7 -40.05%1,17,750-40.86%
3,3750%₹153.05 11.87%1,820₹13.4 -39.36%28,87587.80%
4,875-7.14%₹138.55 16.23%1,840₹16.2 -37.2%18,750-21.87%
21,7500%₹124.8 22.23%1,860₹20.45 -33.6%53,62517.21%
18,750-7.40%₹109 28.76%1,880₹26.05 -30.34%43,500-15.32%
89,250-16.78%₹95 29.16%1,900₹30.5 -32.37%2,17,125-7.65%
1,10,250-6.66%₹81.45 34.62%1,920₹37.75 -27.82%63,750-1.73%
42,000-5.08%₹69.7 37.74%1,940₹45.35 -28.3%47,625-15.89%
1,46,2502.63%₹58.55 40.4%1,960₹53.95 -26.24%2,28,0002.52%
1,40,250163.38%₹49.7 50.15%1,980₹66.2 -20.24%91,12563.08%
3,33,000-14.61%₹41 51.01%2,000₹75.4 -19.18%1,17,750-5.70%
1,26,750-5.32%₹33.75 55.17%2,020₹89.05 -15.51%36,000-6.79%
82,1255.28%₹27.6 56.81%2,040₹91.35 -34.23%13,500-14.28%
61,875-2.36%₹21.75 53.16%2,060₹115.6 -16.65%1,07,2500%
2,18,250-0.17%₹17.7 51.28%2,080₹141.1 0%7,8750%
3,96,375-10.95%₹14.25 46.15%2,100₹152.3 -13.16%19,875-48.03%
42,75032.55%₹11.7 56%2,120₹155.8 0%10,8750%
1,1250%₹9.25 0%2,140₹174.3 0%3,0000%
70,125-0.53%₹7.6 47.57%2,160₹182.15 0%2,2500%
3750%₹47 0%2,180--
1,45,875-0.51%₹5.25 40%2,200₹196.85 0%7,5000%
23,25024%₹4.4 25.71%2,220₹240 0%3750%
22,8753.38%₹3.6 46.93%2,240₹258 -2.54%3,37550%
7500%₹6.65 0%2,260--
22,5000%₹1.85 5.71%2,280--
7,1250%₹1.4 0%2,300₹310 0%38,2500%
62,250-1.19%₹2 90.47%2,320--
20,6250%₹1.4 3.7%2,360--
31,5000%₹3.7 0%2,400--

Glenmark Pharma.: Related NEWS

Glenmark Pharma Q3 FY26 Profit Rises 16% to ₹403.2 Crore

Revenue from North America increased 24% year on year to ₹970.6 crore, including income from the out licensing of ISB 2001.

31 Jan 2026|02:22 PM
Read More
Top Stocks for Today - 25th September 2025

Here are some of the stocks that may see significant price movement today: Polycab India, Tata Steel, Dalmia Bharat, etc.

25 Sep 2025|06:57 AM
Read More
Top Stocks for Today - 23rd September 2025

Here are some of the stocks that may see significant price movement today: Glenmark Pharma, Rail Vikas Nigam, Birla Corp, etc.

23 Sep 2025|07:01 AM
Read More
Glenmark subsidiary gets $700 Million in licensing deal; stock gains

At around 2.19 PM, Glenmark Pharma was trading 2.97% higher at ₹2,112.90 per piece, against the previous close of ₹2,051.90 on NSE.

9 Sep 2025|02:31 PM
Read More
Glenmark Pharma Q1 Net Profit Falls 86% YoY to ₹47 Crore

Operating performance was slightly weaker, with EBITDA dipping 1.4% to ₹580 crore from ₹588.2 crore.

18 Aug 2025|01:03 PM
Read More
Top Stocks for Today - 18th August 2025

Here are some of the stocks that may see significant price movement today: Glenmark Pharmaceuticals, Vedanta, Inox Wind, etc.

18 Aug 2025|08:14 AM
Read More
Glenmark Shares Surge 10% After AbbVie Inks Licensing Deal for ISB 2001

The compound is currently in Phase 1B clinical trials, being studied for multiple myeloma, a tough-to-treat form of blood cancer.

11 Jul 2025|09:48 AM
Read More
Top Stocks for Today - 11th July 2025

Here are some of the stocks that may see significant price movement today: Tata Consultancy Services, IREDA, Glenmark Pharma, etc.

11 Jul 2025|07:20 AM
Read More
Top Stocks for Today - 26th May 2025

Here are some of the stocks that may see significant price movement today: Glenmark Pharma, Ashok Leyland, NTPC, etc.

26 May 2025|06:34 AM
Read More
Glenmark Pharma’s cancer drug receive FDA ‘fast track’ status

ISB 2001 is a tri-specific antibody therapeutic for targeting BCMA and CD38 on myeloma cells, as well as CD3 on T cells.

6 May 2025|09:31 AM
Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.